News Search Results
Oct 07, 2025, 09:15 ET Les auteurs, les éditeurs et les titulaires de droits d'auteur pourraient bénéficier d'un règlement de recours collectif d'un montant de 1,5 milliard de dollars
demande d'indemnisation valide. La Cour a programmé une audience pour le 23 avril 2026, à 12:00 PT au San Francisco Federal Courthouse, 450 Golden Gate Ave, Courtroom 12 - 19th Floor, afin d'examiner s'il convient d'approuver le Règlement. La Cour examinera également
More news about: JND Legal Administration
Oct 07, 2025, 09:15 ET Los autores, editores y propietarios de derechos de autor pueden beneficiarse de un acuerdo de demanda colectiva de $ 1.500 millones
El Tribunal programó una audiencia para el 23 de abril de 2026, a las 12:00 PT en el Palacio de Justicia Federal de San Francisco, 450 Golden Gate Ave., Sala 12 – Piso 19, para considerar si se aprueba el Acuerdo. El Tribunal también considerará la solicitud de los Abogados
More news about: JND Legal Administration
Oct 07, 2025, 09:05 ET From Coast to Coast to Caribbean: Belize Expands Its Runway to Adventure with Nonstop Service From New York, Fort Lauderdale & San Francisco
via United's San Francisco hub. "We are delighted to see these new and returning flight services expand Belize's air connectivity," said Hon. Anthony Mahler, Minister of Tourism, Youth, Sports and Diaspora Relations. "From New York to Fort Lauderdale to San Francisco, these routes
More news about: Belize Tourism Board
Oct 07, 2025, 09:00 ET Curb Flow Launches in San Diego, Enhancing Transit Options and Boosting Driver Earnings
Building on success in Los Angeles and San Francisco, this California expansion meets rising tourism and commuter demand NEW YORK, Oct.
More news about: Curb
Oct 07, 2025, 09:00 ET Persona Achieves FedRAMP® Authorized Status to Expand Identity Verification Solutions for Federal Agencies
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Persona
Oct 07, 2025, 09:00 ET Plaud Launches Developer Platform to Unlock the Missing Half of Conversational Intelligence: In-Person Interactions
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Plaud Inc. today announced the launch of the Plaud Developer Platform, a powerful new way for businesses and developers to integrate and
More news about: PLAUD.AI
Oct 07, 2025, 09:00 ET Juniper Square Acquires Tenor Digital To Expand Private Credit Solutions for GPs
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Juniper Square
Oct 07, 2025, 09:00 ET Match, Bake, Enjoy: Candy Crush® Launches Tasty: The Official Candy Crush Desserts Book
MSFT), has Kingsters in Stockholm, Malmö, London, Barcelona, Berlin, Dublin, San Francisco, New York, Los Angeles and Malta. More information can be found at
More news about: Candy Crush Saga
Oct 07, 2025, 09:00 ET Eve Announces General Availability of AI Intake Platform That Transforms Lead Capture for Plaintiff Firms
integration to maximize revenue opportunities SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Eve
Oct 07, 2025, 09:00 ET Introducing Benchling AI
bringing agents and models to every scientist SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Benchling AI launches today, giving scientists a command center to access
More news about: Benchling
Oct 07, 2025, 09:00 ET Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
Inc. (NASDAQ: GTBP) is a clinical-stage immunotherapy company making significant progress in its fight against difficult-to-treat cancers. The San Francisco-based biotech has been advancing its lead drug candidate, GTB-3650, through a Phase 1 clinical trial targeting blood cancers that have stopped responding
More news about: USA News Group
Oct 07, 2025, 08:32 ET LA's Longest-Running Independent Art Fair "LA Art Show" Kicks Off Art Season on January 7
fascination with astronomy, mythology, and celestial cartography. Other galleries showing at LA Art Show for the first time include Gefen Gallery (San Francisco), Steidel Contemporary (Lake Worth) and Corridor Contemporary (Tel Aviv). LA Art Show will be followed by its East Coast
More news about: LA Art Show
Oct 07, 2025, 08:30 ET Eightco Holdings Inc. ($ORBS) Digital Asset Treasury Launches "Chairman's Message" Video Series
visiting several of the cities where World stores are located, including: October 7: San Francisco October 18-21: Bangkok October 22-23: Kuala Lumpur October 24-25:
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 07, 2025, 08:30 ET Eightco Holdings Inc. ($ORBS) Digital Asset Treasury Launches "Chairman's Message" Video Series
visiting several of the cities where World stores are located, including: October 7: San Francisco October 18-21: Bangkok October 22-23: Kuala Lumpur October 24-25:
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 07, 2025, 08:16 ET Wisner Baum Calls for FDA Accountability as Toxic Metals Remain in Baby Food Products
are taking their own steps to protect children. SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- As the U.S. Food and Drug Administration (FDA) prepares to release its next
More news about: Wisner Baum
Oct 07, 2025, 08:06 ET CLASS ACTION NOTICE: Berger Montague Advises Sina Corporation Investors to Inquire About a Securities Fraud Class Action
Montague Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in
More news about: Berger Montague
Oct 07, 2025, 08:00 ET Golden Gate University Names Brent White as Its 8th President
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- The Golden Gate University (GGU) Board of Trustees today announced the appointment of Brent White as the university's 8th president. White, a proven
More news about: Golden Gate University
Oct 07, 2025, 08:00 ET Cogency Global Collaborates with Change to Accelerate Legal Filing Services for Nonprofits
Change's AI-enabled legal compliance technology SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Change
Oct 07, 2025, 08:00 ET In a Major Breakthrough for Cell and Gene Therapy, Immusoft Has Re-dosed a Patient with ISP-001 in Its Lead Program for MPS I
observe positive results SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Immusoft of CA, a clinical stage, engineered B cell company, today announced
More news about: Immusoft
Oct 07, 2025, 08:00 ET Telmai Brings Autonomous-Ready Data Observability for the Agentic AI Era
natural language interfaces for agentic workflows. SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Telmai
Oct 07, 2025, 08:00 ET Foodsmart Expands Executive Team with Technology, Customer Experience, and Finance Leaders to Advance Foodcare Nationwide
Outcomes for 3+ Million Members Across the U.S. SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Foodsmart, the leading evidenced based nutrition counseling and foodcare platform
More news about: Foodsmart
Oct 07, 2025, 08:00 ET Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
Inc. (NASDAQ: GTBP) is a clinical-stage immunotherapy company making significant progress in its fight against difficult-to-treat cancers. The San Francisco-based biotech has been advancing its lead drug candidate, GTB-3650, through a Phase 1 clinical trial targeting blood cancers that have stopped responding
More news about: Equity Insider
Oct 07, 2025, 07:00 ET Elevate Announces Strategic and Capital Investment in Gilmore Advisors LLC. Expands Bay Area presence with San Mateo-based firm
has invested in Gilmore Advisors LLC, the non-attest business of Gilmore & Associates, LLP, a well-respected San Mateo–based firm serving the San Francisco Peninsula and greater Bay Area. The partnership became effective September 1, 2025.
More news about: Elevate LLC
Oct 07, 2025, 07:00 ET Peer AI Raises $12.1 Million to Accelerate Drug Approvals with an Intelligent Regulatory Workflow
high-quality regulatory documents up to 94% faster SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Peer AI
Oct 07, 2025, 06:00 ET Holiday Travel Trends 2025: Cost, Comfort, and Closer-to-Home Trips
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Sojern
Oct 07, 2025, 06:00 ET Holiday Travel Trends 2025: Cost, Comfort, and Closer-to-Home Trips
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ --
More news about: Sojern
Oct 07, 2025, 06:00 ET InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Impact (KLAS Spotlight 2025) --
More news about: InsightRX
Oct 07, 2025, 06:00 ET New Research Reveals Digital Divide: Southern Young People Face Unique Barriers to Mental Health Support Online
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Hopelab's latest research
More news about: Hopelab
Oct 07, 2025, 03:30 ET Optimum Strategic Communications to Host 17th Annual Healthcare Investor Conference
corporate and financial communications. Our senior team of healthcare specialists, based in London, Amsterdam, New York, Stockholm, San Diego, San Francisco and Zurich, are experienced and trusted advisors to some of the world's most exciting public and private companies, both large and small, across
More news about: Optimum Strategic Communications
Oct 07, 2025, 02:27 ET PRIVACY ALERT: Brightstar Global Solutions Corporation Under Investigation for Data Breach of 103,789 Records
SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to the sensitive information of 103,789 individuals
More news about: Schubert Jonckheer & Kolbe LLP
Oct 06, 2025, 18:05 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
parallel-group, 18-month study evaluating lecanemab in early Alzheimer's disease. Presented at: CTAD Conference; November 29-December 2, 2022; San Francisco, CA. [3] Hampel H, Hardy J, Blennow K, et al. The amyloid-? pathway in Alzheimer's disease.
More news about: BioArctic
Oct 06, 2025, 18:02 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
parallel-group, 18-month study evaluating lecanemab in early Alzheimer's disease. Presented at: CTAD Conference; November 29-December 2, 2022; San Francisco, CA. [3] Hampel H, Hardy J, Blennow K, et al. The amyloid-? pathway in Alzheimer's disease.
More news about: BioArctic
Oct 06, 2025, 17:14 ET ESSA Securityholders Approve Acquisition by XenoTherapeutics
SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce that its Securityholders (as defined
More news about: ESSA Pharma Inc
Oct 06, 2025, 16:30 ET Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease
parallel-group, 18-month study evaluating lecanemab in early Alzheimer's disease. Presented at: CTAD Conference; November 29-December 2, 2022; San Francisco, CA. Hampel H, Hardy J, Blennow K, et al. The amyloid-? pathway in Alzheimer's disease. Mol Psychiatry. 2021;26(10):5481-5503.
More news about: Eisai Inc.